Gilead Fights Monopoly Accusation Over HIV Prevention Drug

Gilead Sciences Inc. has fired back at accusations that it intentionally delayed an improved HIV prevention drug to maximize its monopoly on older drugs, following a petition by a group of...

Already a subscriber? Click here to view full article